Journal of the National Cancer Institute
News brief: Dermatologic infections in cancer patients treated with EGFRI therapy
Published in Gastroenterology Week, December 21st, 2009
This new class of anticancer agents, the EGFRIs, is used against various cancers including lung, pancreatic, breast, head and neck, and colorectal cancers. Patients treated with EGFRIs frequently experience toxic effects such as eruptions of the face, dry, itchy skin and nail inflammation. These side effects affect quality of life, but the impact of these effects on the patients' physical health, such as their...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
More Articles from Gastroenterology Week
- American Society for Gastrointestinal Endoscopy
ASGE issues guidelines on management of antithrombotic agents for endoscopic procedures - DOE/Lawrence Livermore National Laboratory
Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' - Santaris Pharma A/S
New data show breakthrough microRNA-targeted therapy holds promise as new treatment for hepatitis C - Scripps Research Institute
Scripps research team restores some function to cells from cystic fibrosis patients - Weber Shandwick Worldwide
Surgical quality program is a strong tool for assessing outcomes for high-risk procedures - World Journal of Gastroenterology
Spontaneous liver rupture in a patient with peliosis hepatis - More from this issue of Gastroenterology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
